Literature DB >> 19821084

Induction of myelogenous leukemia cells with histone deacetylase inhibitors through down-regulating the Daxx protein expression.

Chunrui Li1, Jianfeng Zhou, Xueqiong Wu, Ye Tian, Jingniu Deng, Wenli Liu.   

Abstract

The effects of two different histone deacetylase (HDAC) inhibitors, sodium butyrate (NaB) and trichostatin A (TSA),on apoptosis of human leukemic cells in vitro and the molecular mechanisms were investigated. The experiments were divided up 5 groups: control group, NaB group, TSA group, NaB+Z-VAD-FMK group and TSA+Z-VAD-FMK group. The apoptosis rate was determined by morphological analysis and flow cytomytry. The expression of Daxx, Bcl-2, and Bcl-xl proteins was detected by Western blot. NaB and TSA could induce the apoptosis of HL-60 and K562 cells, and Z-VAD-FMK caused a marked decrease in apoptosis induced by HDAC inhibitors. HDAC inhibitors could down-regulate the expression of Daxx protein, but had no significant influence on the expression of Bcl-2 and Bcl-xl proteins. The results suggested that NaB and TSA induce distinct caspase-dependent apoptosis of human leukemic cells through down-regulating the expression of Daxx protein in vitro.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821084     DOI: 10.1007/s11596-009-0504-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

Review 1.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

2.  Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.

Authors:  Qinxi Li; Xuan Wang; Xiaoling Wu; Yanning Rui; Wei Liu; Jifeng Wang; Xinghao Wang; Yih-Cherng Liou; Zhiyun Ye; Sheng-Cai Lin
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Combination of SK-7041, one of novel histone deacetylase inhibitors, and STI571-induced synergistic apoptosis in chronic myeloid leukemia.

Authors:  Byung-Su Kim; Eunkyung Bae; Young-Ju Kim; Kwang-Sung Ahn; Juwon Park; Ji Young Rhee; Young Yiul Lee; Youngsoo Kim; Dongsoon Lee; Byoung Kook Kim; Sung-Soo Yoon
Journal:  Anticancer Drugs       Date:  2007-07       Impact factor: 2.248

4.  Inhibition of MEK/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21waf1 promoter in acute myelogenous leukemia cell.

Authors:  C Nishioka; T Ikezoe; J Yang; H P Koeffler; A Yokoyama
Journal:  Leukemia       Date:  2008-01-10       Impact factor: 11.528

5.  Daxx, a novel Fas-binding protein that activates JNK and apoptosis.

Authors:  X Yang; R Khosravi-Far; H Y Chang; D Baltimore
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

6.  Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development.

Authors:  J S Michaelson; D Bader; F Kuo; C Kozak; P Leder
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

7.  A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

Authors:  V M Richon; S Emiliani; E Verdin; Y Webb; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

8.  HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.

Authors:  Michael Tsapis; Michèle Lieb; Fabio Manzo; Pattabhiraman Shankaranarayanan; Raoul Herbrecht; Patrick Lutz; Hinrich Gronemeyer
Journal:  Int J Biochem Cell Biol       Date:  2007-03-15       Impact factor: 5.085

9.  Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.

Authors:  Guillermo Garcia-Manero; Sarit Assouline; Jorge Cortes; Zeev Estrov; Hagop Kantarjian; Hui Yang; Willie M Newsome; Wilson H Miller; Caroline Rousseau; Ann Kalita; Claire Bonfils; Marja Dubay; Tracy-Ann Patterson; Zuomei Li; Jeffrey M Besterman; Gregory Reid; Eric Laille; Robert E Martell; Mark Minden
Journal:  Blood       Date:  2008-05-21       Impact factor: 22.113

Review 10.  Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy.

Authors:  Jennifer S Carew; Francis J Giles; Steffan T Nawrocki
Journal:  Cancer Lett       Date:  2008-05-06       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.